|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
1999-2-3
|
|
pubmed:abstractText |
The incidence of skin rashes or erythema multiforme to sulfamethoxazole in exposed patients is about 3%. Among patients with acquired immunodeficiency syndrome the risk is approximately 10 times higher. The pathogenesis of these reactions and the reason for the increased frequency in HIV infections are not understood.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0954-7894
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1412-7
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9824415-CD4-Positive T-Lymphocytes,
pubmed-meshheading:9824415-CD8-Positive T-Lymphocytes,
pubmed-meshheading:9824415-Cell Line,
pubmed-meshheading:9824415-Clone Cells,
pubmed-meshheading:9824415-Cytotoxicity, Immunologic,
pubmed-meshheading:9824415-HLA-B Antigens,
pubmed-meshheading:9824415-HLA-B44 Antigen,
pubmed-meshheading:9824415-HLA-DR Antigens,
pubmed-meshheading:9824415-Humans,
pubmed-meshheading:9824415-Immunohistochemistry,
pubmed-meshheading:9824415-Interferon-gamma,
pubmed-meshheading:9824415-Keratinocytes,
pubmed-meshheading:9824415-Male,
pubmed-meshheading:9824415-Membrane Glycoproteins,
pubmed-meshheading:9824415-Perforin,
pubmed-meshheading:9824415-Pore Forming Cytotoxic Proteins,
pubmed-meshheading:9824415-Skin Tests,
pubmed-meshheading:9824415-Sulfamethoxazole,
pubmed-meshheading:9824415-T-Lymphocytes
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction.
|
|
pubmed:affiliation |
Institute of Immunology and Allergology, Inselspital, Bern, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
